Sanofi and whistleblower settle 19-year battle with FCA against cancer


By Dorothy Atkins (Nov 8, 2021, 8:58 p.m. EST) – A whistleblower voluntarily dropped his 19-year False Claims Act lawsuit, alleging drugmaker Sanofi US Services Inc. deceptively promoted uses non-compliant for his cancer drug treatment, after the parties reached a confidential settlement less than three months before the trial began.

In a two-page notice on Friday, Sanofi and former sales representative Yoash Gohil informed U.S. District Judge Anita B. Brody of the Eastern District of Pennsylvania that Gohil has agreed to voluntarily dismiss its remaining FCA claims against the maker of medication, as well as his claims for attorney. fees and costs.

The dismissal has been occurring for decades in a dispute, which had …

Stay one step ahead

In the legal profession, information is the key to success. You need to know what’s going on with customers, competitors, practice areas, and industries. Law360 provides the intelligence you need to stay an expert and beat the competition.

  • Access to case data in articles (numbers, filings, courts, nature of prosecution, etc.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, requests, etc.
  • Create personalized alerts for specific case articles and topics and more!


Leave A Reply

Your email address will not be published.